Our Companies

Medical Marijuana, Inc. owns 100% of HempMeds® Mexico

HempMeds® Mexico is Medical Marijuana Inc.’s distribution branch in the country, focusing on providing non-psychoactive cannabidiol products to the people in Mexico. HempMeds® Mexico was the first company to have a medical cannabis product approved for import into Mexico, a country that is in the process of restructuring their policies regarding cannabis.

HempMeds® Mexico supports patients as they navigate the process of approval for RSHO-X™, which is currently available with a prescription. The HempMeds® Mexico team assists patients in applying for a certificate for import and allows approved patients to order RSHO-X™ directly from their website.

It is the goal of HempMeds® Mexico to facilitate each point in the process for all qualifying patients who are interested in accessing CBD hemp oil. Medical Marijuana, Inc. and HempMeds® Mexico are also working with partners and health organizations in Mexico to improve the approval process that applications must go through, so patients can become approved for RSHO-X™ more easily and efficiently.

Launched in January 2016, HempMeds® Mexico staffs a team of bilingual customer service representatives and outreach specialists, as well as partnerships with leading nonprofits, to bring RSHO-X™ to patients in Mexico.

HempMeds® Mexico was the first company to have a medical cannabis product approved for import into Mexico

Mexico began to allow the use of cannabidiol (CBD) for patients with a doctor’s prescription, but the government remained resolutely averse to any products with even trace amounts of tetrahydrocannabinol (THC) in them.

In order to import our CBD hemp oil to Mexico, we had to develop a product completely free of THC. Medical Marijuana, Inc. achieved this by isolating the CBD within our hemp oil, thus eliminating the trace amounts of THC in our hemp oil to make RSHO-X™.

In January of 2016, Medical Marijuana, Inc. participated in and sponsored educational events aimed at raising awareness among patients for cannabidiol (CBD) hemp oil. This participation included having Medical Marijuana, Inc. CEO Dr. Stuart Titus educate decision makers about the endocannabinoid system and the effects of cannabinoids, including cannabidiol from hemp.

In many cases, the Mexican citizens attending these forums were looking to medical marijuana and cannabidiol (CBD) hemp oil as potential treatments for conditions that traditional medicines could not help with. To that end, Medical Marijuana Inc. has been working closely with our nonprofit partner in Mexico, the Por Grace Por Todos Foundation.

These educational events were also intended to relay the correct information about CBD to Mexican health officials, lawmakers, and doctors, so they can make qualified decisions about the role of CBD products in the Mexican healthcare system.

Over 30 national news outlets followed this milestone for Medical Marijuana, Inc. and access to medical cannabis in Mexico, highlighting the benefits of CBD hemp oil. They speculated that the Mexican CBD market to be worth $12 billion and could replace up to 40% of the drugs used for neurodegenerative diseases.

Medical Marijuana Inc. is working to legally export products to customers in Mexico through HempMeds® Mexico. If you have any questions about the process, you can learn more at HempMeds® Mexico for specifics, or call HempMeds® Mexico at: 001-883-786-2440 (Mexico) or 1-866-786-2440 (US).